WitrynaAMLODIPINE IMPURITY A CRS Safety Data Sheet Safety Data Sheet in accordance with Regulation (EC) No. 1907/2006, as amended. Date of issue: 27/06/2013 Revision date: 27/06/2013 Supersedes: 27/11/2009 Version: 3.1 05/08/2013 EN (English) 1/6 … WitrynaThe EC Number is the numerical identifier for substances in the EC Inventory. The EC Inventory is a combination of three independent European lists of substances from the previous EU chemicals regulatory frameworks (EINECS, ELINCS and the NLP-list). More information about the EC Inventory can be found here. If the substance was not …
Commission Implementing Decision of 25 November 2013 on
WitrynaREACH regulation aims to improve the protection of human health and the environment from the risks that can be posed by chemicals. Understanding REACH Legislation Substance identification Communication in the supply chain Use maps templates Safety data sheets Candidate List substances in articles Registration Basics of registration WitrynaThe substance identifiers displayed in the InfoCard are the best available substance name, EC number, CAS number and/or the molecular and structural formulas. Some substance identifiers may have been claimed confidential, or may not have been … different models of toyota
OPINION on Dichloromethane - European Commission
WitrynaImpurities that occur due to process variability in quantities ( 1 g/kg in the active substance as manufactured, based on dry weight, are regarded as significant. Relevant impurities All impurities of toxicological and/or ecotoxicological or environmental concern compared with the active substance, even if present in technical material at < … WitrynaShould not be used with nitrosating systems and should be kept in nitrite-free environments. 61. Monoalkylamines, monoalkanolamines and their salts. Maximum … Witrynaimpurities and additives in the technical active substance (T.A.S.) and, active substance, relevant impurities and relevant co-formulants (where required by the national competent authority) in the plant protection product. 2.1. Scope This document has been prepared to provide guidance to applicants on the requirements for for medicinal purposes